中国·皇冠新体育|官方网站-手机版App Store下载

Symbiox® Listed in Catalog of Medicine covered by national medical insurance system 

First in class drug Symbiox ® obtained registration certificate

Mr. Zhang Yongming became controlling shareholder

Guanhao acquired Beijing Wenfeng Tianji Pharma, and Guangdong Zhonghao Pharma.

Guanhao acquired Zhuhai Sunny Medical Device Co., Ltd.

Guanhao and Peking University co-founded Bei Hao Research Stem Cell and Regenerative Research Institute

Guanhao began industrialization of immunocyte storage technology

Founded "Guangdong Guanhao Life and Health Industry Park"

Listed on the GEM board of China Shenzhen Stock Exchange

Awarded by the National Development and Reform Commission for the Construction of the State’s High-tech Industrialization Demonstration Project

Awarded by the National Development and Reform Commission for the construction of the National Engineering Laboratory for Regenerative Implantable Medical Devices

Obtained Approval for first product NormalGEN® dura repair patch